Endoscopic Flexor Hallucis Longus Transfer vs Minimally Invasive Repair in Acute Achilles Tendon Rupture
Launched by ARISTOTLE UNIVERSITY OF THESSALONIKI · Oct 28, 2023
Trial Information
Current as of July 22, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
Two separate foot and ankle surgeons in Northern Greece prefer to use a different surgical technique in their respective patients with Acute Achilles tendon rupture.
The first one (A.E.) prefers to perform only Endoscopic Flexor Hallucis Longus transfer, while the second one (P.S.) prefers to perform only Minimally invasive primary repair assisted by the Achillon device (Percutaneous Achilles Repair System - PARS). They both agreed to enroll their recently operated patients (last 5 years) in this retrospective study, which will be conducted by the researcher (M.K.). The patient's study may...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Signed Consent Form
- • Age between 18-75 years
- • Acute Achilles Tendon Rupture (\<3 weeks)
- • Surgical Management with Endoscopic Flexor Hallucis Longus transfer or Minimally Invasive primary tendon repair
- • More than 12 months postoperative follow-up
- • Patients operated after 2015
- Exclusion Criteria:
- • Inability or Unwillingness to cooperate
- • Medically unfit for examination (e.g. due to terminal illness)
- • Age less than 18 or more than 75 years
- • Non-operative Management as definitive treatment
- • Surgical Management other than the ones described in the inclusion criteria
- • Neglected Achilles Tendon Rupture (\>3 weeks)
- • Bilateral Achilles Tendon Rupture
- • Patients operated before 2015
- • Comorbidities interfering with the secondary outcomes (e.g. Venous insufficiency resulting in lower limb excessive edema interferes with ankle and calf circumference, rheumatoid arthritis and/or previous foot and ankle surgery interferes with active and passive range of motion of the ankle, etc)
About Aristotle University Of Thessaloniki
Aristotle University of Thessaloniki (AUTH) is a prestigious institution in Greece, renowned for its commitment to advancing knowledge and innovation in the field of clinical research. As a leading academic sponsor of clinical trials, AUTH leverages its extensive resources and expertise to conduct rigorous studies that contribute to the understanding of various medical conditions and the development of novel therapeutic interventions. The university fosters collaboration among multidisciplinary teams, ensuring adherence to the highest ethical standards and regulatory requirements while promoting scientific excellence and enhancing patient care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Náousa, Central Macedonia, Greece
Patients applied
Trial Officials
Michail K. Kotsapas, MD, MSc
Principal Investigator
Aristotle University Of Thessaloniki
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported